Literature DB >> 31308061

Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.

Sriram Sundaravel1, Wen-Liang Kuo1, Jong Jin Jeong1, Gaurav S Choudhary2, Shanisha Gordon-Mitchell2, Hui Liu1, Tushar D Bhagat2, Kathy L McGraw3, Sandeep Gurbuxani4, Alan F List3, Amit Verma2, Amittha Wickrema5.   

Abstract

PURPOSE: Myelodysplastic syndromes (MDS) with deletion of chromosome 7q/7 [-7/(del)7q MDS] is associated with worse outcomes and needs novel insights into pathogenesis. Reduced expression of signaling protein dedicator of cytokinesis 4 (DOCK4) in patients with -7/(del)7q MDS leads to a block in hematopoietic stem cell (HSC) differentiation. Identification of targetable signaling networks downstream of DOCK4 will provide means to restore hematopoietic differentiation in MDS.Experimental Design: We utilized phosphoproteomics approaches to identify signaling proteins perturbed as a result of reduced expression of DOCK4 in human HSCs and tested their functional significance in primary model systems.
RESULTS: We demonstrate that reduced levels of DOCK4 lead to increased global tyrosine phosphorylation of proteins in primary human HSCs. LYN kinase and phosphatases INPP5D (SHIP1) and PTPN6 (SHP1) displayed greatest levels of tyrosine phosphorylation when DOCK4 expression levels were reduced using DOCK4-specific siRNA. Our data also found that increased phosphorylation of SHIP1 and SHP1 phosphatases were due to LYN kinase targeting these phosphatases as substrates. Increased migration and impediment of HSC differentiation were consequences of these signaling alterations. Pharmacologic inhibition of SHP1 reversed these functional aberrations in HSCs expressing low DOCK4 levels. In addition, differentiation block seen in DOCK4 haplo-insufficient [-7/(del)7q] MDS was rescued by inhibition of SHP1 phosphatase.
CONCLUSIONS: LYN kinase and phosphatases SHP1 and SHIP1 are perturbed when DOCK4 expression levels are low. Inhibition of SHP1 promotes erythroid differentiation in healthy HSCs and in -7/(del)7q MDS samples with low DOCK4 expression. Inhibitors of LYN, SHP1 and SHIP1 also abrogated increased migratory properties in HSCs expressing reduced levels of DOCK4. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31308061      PMCID: PMC6744990          DOI: 10.1158/1078-0432.CCR-19-0924

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  48 in total

Review 1.  Myelodysplasia.

Authors:  M L Heaney; D W Golde
Journal:  N Engl J Med       Date:  1999-05-27       Impact factor: 91.245

2.  SHP1 protein tyrosine phosphatase negatively modulates erythroid differentiation and suppression of apoptosis in J2E erythroleukemic cells.

Authors:  T Bittorf; J Seiler; Z Zhang; R Jaster; J Brock
Journal:  Biol Chem       Date:  1999-10       Impact factor: 3.915

3.  Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells.

Authors:  B O'Laughlin-Bunner; N Radosevic; M L Taylor; C DeBerry; D D Metcalfe; M Zhou; C Lowell; D Linnekin
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

4.  Engagement of Gab1 and Gab2 in erythropoietin signaling.

Authors:  A Wickrema; S Uddin; A Sharma; F Chen; Y Alsayed; S Ahmad; S T Sawyer; G Krystal; T Yi; K Nishada; M Hibi; T Hirano; L C Platanias
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

5.  Defective expression of the SHP-1 phosphatase in polycythemia vera.

Authors:  A Wickrema; F Chen; F Namin; T Yi; S Ahmad; S Uddin; Y H Chen; L Feldman; W Stock; R Hoffman; L C Platanias
Journal:  Exp Hematol       Date:  1999-07       Impact factor: 3.084

6.  DOCK4, a GTPase activator, is disrupted during tumorigenesis.

Authors:  Vijay Yajnik; Charles Paulding; Raffaella Sordella; Andrea I McClatchey; Mako Saito; Doke C R Wahrer; Paul Reynolds; Daphne W Bell; Robert Lake; Sander van den Heuvel; Jeff Settleman; Daniel A Haber
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

7.  Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1.

Authors:  Kenneth W Harder; Cathy Quilici; Edwina Naik; Melissa Inglese; Nicole Kountouri; Amanda Turner; Kristina Zlatic; David M Tarlinton; Margaret L Hibbs
Journal:  Blood       Date:  2004-08-31       Impact factor: 22.113

8.  The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity.

Authors:  Christopher P Baran; Susheela Tridandapani; Cheryl D Helgason; R Keith Humphries; Gerald Krystal; Clay B Marsh
Journal:  J Biol Chem       Date:  2003-07-25       Impact factor: 5.157

9.  Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells.

Authors:  A Wickrema; S B Krantz; J C Winkelmann; M C Bondurant
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

10.  An isoform of GTPase regulator DOCK4 localizes to the stereocilia in the inner ear and binds to harmonin (USH1C).

Authors:  D Yan; F Li; M L Hall; C Sage; W-H Hu; Cosmas Giallourakis; Geeta Upadhyay; X M Ouyang; L L Du; John R Bethea; Z Y Chen; V Yajnik; X Z Liu
Journal:  J Mol Biol       Date:  2006-01-23       Impact factor: 5.469

View more
  5 in total

1.  Long Noncoding RNA EBLN3P Promotes the Progression of Liver Cancer via Alteration of microRNA-144-3p/DOCK4 Signal.

Authors:  Hang Li; Min Wang; Hui Zhou; Shan Lu; Bo Zhang
Journal:  Cancer Manag Res       Date:  2020-09-29       Impact factor: 3.989

Review 2.  Epigenetic modifiers in normal and aberrent erythropoeisis.

Authors:  Sriram Sundaravel; Ulrich Steidl; Amittha Wickrema
Journal:  Semin Hematol       Date:  2020-12-29       Impact factor: 3.851

3.  Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro Models.

Authors:  Eros Di Giorgio; Harikrishnareddy Paluvai; Raffaella Picco; Claudio Brancolini
Journal:  Int J Mol Sci       Date:  2019-12-12       Impact factor: 5.923

4.  USP36-Mediated Deubiquitination of DOCK4 Contributes to the Diabetic Renal Tubular Epithelial Cell Injury via Wnt/β-Catenin Signaling Pathway.

Authors:  Suwei Zhu; Shaoshuai Hou; Yao Lu; Wei Sheng; Zhengguo Cui; Tianyi Dong; Hong Feng; Qiang Wan
Journal:  Front Cell Dev Biol       Date:  2021-04-23

5.  Modulation of the Pol II CTD Phosphorylation Code by Rac1 and Cdc42 Small GTPases in Cultured Human Cancer Cells and Its Implication for Developing a Synthetic-Lethal Cancer Therapy.

Authors:  Bo Zhang; Xuelin Zhong; Moira Sauane; Yihong Zhao; Zhi-Liang Zheng
Journal:  Cells       Date:  2020-03-04       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.